Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–78.
Article CAS PubMed Google Scholar
Martini A, Lovell DJ, Albani S, Brunner HI, Hyrich KL, Thompson SD, et al. Juvenile idiopathic arthritis. Nat Rev Dis Primers. 2022;8(1):5.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.
Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. The Lancet. 2011;377(9783):2138–49. https://doi.org/10.1016/S0140-6736(11)60244-4
Martini A. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? J Rheumatol. 2003;30(9):1900–3.
Martini A. New takes on categorization and treatment. Nat Rev Rheumatol. 2012;8(2):67–8.
Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F, et al. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era. Arthritis Res Ther. 2019;21(1):168.
Article PubMed PubMed Central Google Scholar
Daniluk U, Daniluk J, Kucharski R, Kowalczyk T, Pietrowska K, Samczuk P, et al. Untargeted metabolomics and inflammatory markers profiling in Children with Crohn’s Disease and Ulcerative Colitis—A preliminary study. Inflamm Bowel Dis. 2019;25(7):1120–8.
Robinson GA, Peng J, Pineda-Torra I, Ciurtin C, Jury EC. Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE patients Associated with inflammation and potential Cardiovascular Disease Risk. Metabolites. 2021;12(1):3.
Article PubMed PubMed Central Google Scholar
Kapoor SR, McGrath CM, Fitzpatrick MA, Young SP. Metabolomics in rheumatology. Rheumatology. 2015;kev334.
Giacalone VD, Cammarata-Mouchtouris A, Moncada-Giraldo D, Shenoy SPV, Ponder LA, Gergely TR, et al. Immunometabolic analysis of Synovial Fluid from Juvenile Idiopathic Arthritis patients. Immunohorizons. 2022;6(11):768–78.
Article CAS PubMed Google Scholar
Lewis KA, Osier N, Carrasco R, Chiou J, Carter P, Garcia A, et al. Serine, N-acetylaspartate differentiate adolescents with juvenile idiopathic arthritis compared with healthy controls: a metabolomics cross-sectional study. Pediatr Rheumatol. 2022;20(1):12.
Funk RS, Becker ML. Metabolomic profiling identifies exogenous and microbiota-derived metabolites as markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis. Front Pharmacol. 2021;12.
Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451–9.
Article CAS PubMed PubMed Central Google Scholar
Ivanisevic J, Elias D, Deguchi H, Averell PM, Kurczy M, Johnson CH, et al. Arteriovenous blood metabolomics: a readout of Intra-tissue Metabostasis. Sci Rep. 2015;5(1):12757.
Article CAS PubMed PubMed Central Google Scholar
Zhang A, Sun H, Qiu S, Wang X. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magn Reson Chem. 2013;51(9):549–56.
Article CAS PubMed Google Scholar
Cedeno M, Murillo-Saich J, Coras R, Cedola F, Brandy A, Prior A, et al. Serum metabolomic profiling identifies potential biomarkers in arthritis in older adults: an exploratory study. Metabolomics. 2023;19(4):37.
Article CAS PubMed PubMed Central Google Scholar
Xu L, Chang C, Jiang P, Wei K, Zhang R, Jin Y et al. Metabolomics in rheumatoid arthritis: advances and review. Front Immunol. 2022;13.
Gupta L, Ahmed S, Jain A, Misra R. Emerging role of metabolomics in rheumatology. Int J Rheum Dis. 2018;21(8):1468–77.
Julkunen H, Cichońska A, Tiainen M, Koskela H, Nybo K, Mäkelä V, et al. Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat Commun. 2023;14(1):604.
Article CAS PubMed PubMed Central Google Scholar
Otvos JD, Shalaurova I, Wolak-Dinsmore J, Connelly MA, Mackey RH, Stein JH, et al. GlycA: a Composite Nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem. 2015;61(5):714–23.
Article CAS PubMed Google Scholar
Lorenzo C, Festa A, Hanley AJ, Rewers MJ, Escalante A, Haffner SM. Novel protein glycan–derived markers of systemic inflammation and C-Reactive protein in relation to Glycemia, insulin resistance, and insulin secretion. Diabetes Care. 2017;40(3):375–82.
Article CAS PubMed Google Scholar
Lawler PR, Akinkuolie AO, Chandler PD, Moorthy MV, Vandenburgh MJ, Schaumberg DA, et al. Circulating N-Linked glycoprotein acetyls and longitudinal mortality risk. Circ Res. 2016;118(7):1106–15.
Article CAS PubMed PubMed Central Google Scholar
Ritchie SC, Würtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, et al. The Biomarker GlycA is Associated with chronic inflammation and predicts long-term risk of severe infection. Cell Syst. 2015;1(4):293–301.
Article CAS PubMed Google Scholar
Bartlett DB, Connelly MA, AbouAssi H, Bateman LA, Tune KN, Huebner JL, et al. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls. Arthritis Res Ther. 2016;18(1):86.
Article PubMed PubMed Central Google Scholar
Ormseth MJ, Chung CP, Oeser AM, Connelly MA, Sokka T, Raggi P, et al. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis. Arthritis Res Ther. 2015;17(1):117.
Article PubMed PubMed Central Google Scholar
Ellis JA, Ponsonby AL, Pezic A, Chavez RA, Allen RC, Akikusa JD, et al. CLARITY – ChiLdhood Arthritis Risk factor identification sTudY. Pediatr Rheumatol. 2012;10(1):37.
LURATI A, SALMASO A, GERLONI V. Accuracy of Wallace Criteria for Clinical Remission in Juvenile Idiopathic Arthritis: a Cohort Study of 761 consecutive cases. J Rheumatol. 2009;36(7):1532–5.
Mansell T, Saffery R, Burugupalli S, Ponsonby AL, Tang ML, O’Hely M et al. Early life infection and proinflammatory, atherogenic metabolomic and lipidomic profiles in infancy: a population-based cohort study. Elife. 2022;11.
Ellul S, Wake M, Clifford SA, Lange K, Würtz P, Juonala M, et al. Metabolomics: population epidemiology and concordance in Australian children aged 11–12 years and their parents. BMJ Open. 2019;9(Suppl 3):106–17.
Article PubMed PubMed Central Google Scholar
Juonala M, Ellul S, Lawlor DA, Santos Ferreira DL, Carlin JB, Cheung M, et al. A Cross-cohort Study examining the associations of Metabolomic Profile and subclinical atherosclerosis in children and their parents: the Child Health CheckPoint Study and Avon Longitudinal Study of Parents and children. J Am Heart Assoc. 2019;8(14):e011852.
Article CAS PubMed PubMed Central Google Scholar
Benjamini Y, Hochberg Y. Controlling the false Discovery rate: a practical and powerful Approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289–300.
Würtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -Omic technologies. Am J Epidemiol. 2017;186(9):1084–96.
Article PubMed PubMed Central Google Scholar
Jury EC, Peng J, Van Vijfeijken A, Martin Gutierrez L, Woodridge L, Wincup C et al. Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk. Rheumatology. 2023.
Fang XY, Zhang J, Qian TT, Gao P, Wu Q, Fang Q, et al. Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank. RMD Open. 2023;9(4):e003560.
Article PubMed PubMed Central Google Scholar
Gorczyca D, Postępski J, Czajkowska A, Paściak M, Prescha A, Olesińska E, et al. The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity. Clin Rheumatol. 2017;36(6):1269–79.
Comments (0)